Antibiotics were once considered a medical miracle, capable of stopping the most terrifying infections. Today, humanity is increasingly confronted with a phenomenon that is causing concern not only among doctors but also among scientists and governments around the world: antibiotic resistance . This problem is already claiming lives, and in the future, it could make even simple infections fatal. Against this backdrop, interest in alternatives is growing. And bacteriophages, viruses that destroy bacteria, appear to be one of the most promising.

Antibiotic resistance is a silent pandemic.

The World Health Organization calls antibiotic resistance one of the greatest threats to humanity in the 21st century. It is estimated that more than 1.2 million people die each year from drug-resistant infections, and this figure is steadily growing. This is due to the excessive and uncontrolled use of antibiotics in human medicine, veterinary medicine, and agriculture. Bacteria adapt, mutate, and become invulnerable to traditional treatments.

Even worse, the development of new antibiotics has virtually ground to a halt. Pharmaceutical companies are reluctant to invest in drugs that quickly lose effectiveness. In this situation, medicine needs a new approach.

Bacteriophages: An old solution with new potential

Although the term "phage therapy" sounds new, bacteriophages have been known since the early 20th century. They were discovered by the French microbiologist Félix d'Hérelle in 1917, and even then they demonstrated their ability to effectively combat bacterial infections. Unlike antibiotics, which kill a broad spectrum of microorganisms, including beneficial ones, phages act selectively, infecting only specific strains and leaving the beneficial microflora intact. This is not only more effective but also safer—the risk of side effects is significantly lower. Furthermore, these hunter-killer viruses can evolve alongside bacteria, maintaining their effectiveness even when the pathogens mutate.

Where are bacteriophages already used?

The most renowned phage therapy center is the Eliava Institute in Georgia, where this field has been practiced since the 1920s. Patients from all over the world—Canada, Germany, the United States, Italy, and Japan—come to Tbilisi, many of whom have failed to respond to traditional treatments. In Ukraine, there are also officially registered phage preparations available in pharmacies. In the United States, phage therapy is approved for use in exceptional cases, particularly for patients with infections resistant to all antibiotics, and pilot programs are underway in France and Belgium.

Problems and Prospects

Despite its undeniable advantages, phage therapy faces a number of challenges. The primary one is the need for personalized treatment: a single phage cannot kill all bacteria of a single species; it only targets a specific strain, requiring a customized treatment for each patient. Another barrier is the lack of a regulatory framework: in most countries, phage preparations are not yet officially approved as drugs. This hinders their introduction into clinical practice.

However, the situation is changing. The European Union is already discussing the creation of specific regulations for phage therapy, and scientific research supported by governments and private investors is opening new horizons. Automated systems for selecting bacteriophages are emerging, and clinical trials are being conducted on a scale unimaginable just ten years ago.

Can we live without antibiotics?

Phages are unlikely to completely replace antibiotics, but significantly reducing their use is entirely possible. In the near future, we expect phages to be actively integrated into the healthcare system: as supportive therapy and as a full-fledged replacement for antibiotics in certain cases. These viruses are already being used in surgery, dermatology, gastroenterology, and even pediatrics, and with each successful case, confidence in the method grows. Bacteriophages offer a chance to change the course of medical development and, perhaps, the best hope for a future without antibiotics.